Vision Scs F2 Cullinan Oncology, Inc. (CGEM) insider trading activity

Vision Scs F2 is > 10% Shareholder of Cullinan Oncology, Inc.. Currently has a direct ownership of 1.26 Million shares of CGEM, which is worth approximately $19.8 Million. The most recent transaction as insider was on Aug 04, 2022, when has been sold 25,989 shares (Common Stock) at a price of $14.31 per share, resulting in proceeds of $371,903. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.26M

0% 3M change

0% 12M change

Total Value Held $19.8 Million

Vision SCS F2 Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 04 2022	SELL Open market or private sale	$371,903 $14.31 p/Share	25,989 Reduced 2.03%	1,255,963 Common Stock
Aug 03 2022	SELL Open market or private sale	$272,397 $14.24 p/Share	19,129 Reduced 1.47%	1,281,952 Common Stock
Aug 02 2022	SELL Open market or private sale	$67,567 $14.1 p/Share	4,792 Reduced 0.37%	1,301,081 Common Stock
May 16 2022	SELL Open market or private sale	$394,824 $11.23 p/Share	35,158 Reduced 2.62%	1,305,873 Common Stock
May 13 2022	SELL Open market or private sale	$1,221,372 $10.22 p/Share	119,508 Reduced 8.18%	1,341,031 Common Stock
May 12 2022	SELL Open market or private sale	$2,442,666 $9.25 p/Share	264,072 Reduced 15.31%	1,460,539 Common Stock
Jan 11 2022	SELL Other acquisition or disposition	-	1,187,734 Reduced 40.78%	1,724,611 Common Stock

VSF

Vision Scs F2

> 10% Shareholder

Luxemburg, V8

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account